MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ecco-jcc/jjaf183

Медицинская библиотека · Journal of Crohn's & colitis · 2025

Therapeutic management and risk of colectomy in patients with acute severe ulcerative colitis and previous exposure to anti-tumor necrosis factor drugs: a comparative study of GETECCU.

Mesonero Francisco, Alicia López-García, José Miranda-Bautista, Cristina Rubín de Célix, Ignacio Marín-Jiménez, Cristina Suárez Ferrer, Albert Martin-Cardona, Esteban Fuentes-Valenzuela, Alejando Mínguez, Andrés Castaño, Cristina Roig, Agnès Fernández-Clotet, Jerusalén Gargallo-Puyuelo Carla, Begoña Álvarez Herrero, José García María, José Xavier Segarra-Ortega, Carmen Rodríguez-Grau María, Francisco López Romero-Salazar, Ignacio Omella, Daniel Martín-Rodríguez, María González Vivo, Ángel Ponferrada-Díaz, Iria Baston-Rey, María Benítez José, Cristina Reygosa, Alejandro Lastiri González Ernesto, Genaro Delgado-Guillena Pedro, Leyanira Torrealba, Alejandro Hernández-Camba, Lorena Bernal, Gisela Piñero, Eduard Brunet, Martín Irabien, Miquel Marquès-Camí, Yamile Zabana, Ana Gutiérrez, Young Group of GETECCU

СтатьяСравнительное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Data on the management of acute severe ulcerative colitis (ASUC) in patients with prior anti-tumor necrosis factor (anti-TNF) exposure are limited. We compared medical management, colectomy risk, and mortality between anti-TNF-exposed and bio-naive patients.

METHODS

This retrospective, multicenter GETECCU study included two ASUC cohorts (2010-2020): anti-TNF-exposed (cohort 1) and bio-naive (cohort 2). Patients previously treated with other advanced therapies were excluded. Steroid response was defined by reduced bowel movements and C-reactive protein. Rescue therapies were used for steroid failure. Maintenance therapy was initiated post-ASUC. Clinical effectiveness was assessed using the partial Mayo score (remission ≤2). Colectomy rates were analyzed through survival analysis and Cox regression. Mortality at 12 months was also evaluated.

RESULTS

A total of 461 patients were included: 149 in cohort 1 and 312 in cohort 2. Steroid use was lower in cohort 1 (82% vs 97%, P < .001), but clinical response rates were similar. Rescue therapy rates were comparable (52% vs 57%, P = .88); infliximab use was lower in cohort 1 (25% vs 54%, P < .01). At 12 months, cohort 1 showed lower remission (44% vs 59%, P = .03) and higher colectomy (17% vs 8.7%, P = .01). Overall colectomy was higher in cohort 1 (34% vs 17%; hazard ratio 2.46, P = .001). One-year mortality was 1.52% (no significant differences between cohorts).

CONCLUSION

ASUC management in anti-TNF-exposed patients is heterogeneous and differs from that of bio-naive patients, with increased risk of treatment failure and colectomy.

Для цитирования: Mesonero Francisco, Alicia López-García, José Miranda-Bautista, Cristina Rubín de Célix, Ignacio Marín-Jiménez, Cristina Suárez Ferrer, Albert Martin-Cardona, Esteban Fuentes-Valenzuela, Alejando Mínguez, Andrés Castaño, Cristina Roig, Agnès Fernández-Clotet, Jerusalén Gargallo-Puyuelo Carla, Begoña Álvarez Herrero, José García María, José Xavier Segarra-Ortega, Carmen Rodríguez-Grau María, Francisco López Romero-Salazar, Ignacio Omella, Daniel Martín-Rodríguez, María González Vivo, Ángel Ponferrada-Díaz, Iria Baston-Rey, María Benítez José, Cristina Reygosa, Alejandro Lastiri González Ernesto, Genaro Delgado-Guillena Pedro, Leyanira Torrealba, Alejandro Hernández-Camba, Lorena Bernal, Gisela Piñero, Eduard Brunet, Martín Irabien, Miquel Marquès-Camí, Yamile Zabana, Ana Gutiérrez, Young Group of GETECCU. Therapeutic management and risk of colectomy in patients with acute severe ulcerative colitis and previous exposure to anti-tumor necrosis factor drugs: a comparative study of GETECCU.. Journal of Crohn's & colitis. 2025. DOI: 10.1093/ecco-jcc/jjaf183.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.